Evolent Health, Inc.EVHNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Below historical average.
Left:
|
|
|
|

Year-over-year research & development expense growth

Latest
0.00%
↓ 100% below average
Average (39q)
93.10%
Historical baseline
Range
High:2800.00%
Low:-100.00%
Volatility
3114.9%
High variability
PeriodValue
Q3 20250.00%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 2024-100.00%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%
Q3 20220.00%
Q2 20220.00%
Q1 2022-100.00%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 2019-100.00%
Q3 20198.89%
Q2 20199.76%
Q1 2019-86.60%
Q4 20180.00%
Q3 2018-100.00%
Q2 201816.00%
Q1 2018-87.05%
Q4 20171508.33%
Q3 201733.33%
Q2 201728.57%
Q1 2017-93.97%
Q4 20162800.00%
Q3 201633.33%
Q2 201650.00%
Q1 2016-96.55%
Q4 20150.00%